Clin2
NCT07210281Possibly a fitRecruiting

Osteogenon study for bone healing after injury or surgery

Patients With Fractures

Part of Injuries & trauma clinical trials.

This trial tests Osteogenon, a medication that may help bones heal better after fractures or orthopedic surgery. It aims to see if the drug improves bone union and recovery.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
150 people
Ages
18 years to 85 years
Study type
Interventional

Who can take part

  • You must be between 18 and 85 years old.
  • You should not be taking any other medicines that affect bone healing (like certain diuretics).
  • You need to have complete medical records and X-rays available.
  • You must be able to attend follow-up visits for at least 3 months after treatment.
  • You cannot have severe kidney problems, high calcium levels, or certain bone or nerve conditions.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07209033Recruiting
Testing FlexiOss for bone repair in leg and foot fractures

This trial tests a new material called FlexiOss to help heal broken bones in the leg or foot. It aims to see if the material is safe and effective for bone regeneration.

Krakow
NCT03024008Recruiting· Phase 1/Phase 2
Study of bone-healing paste from your own cells for broken bones

This trial tests a bone-healing product made from your own tissue (“autologous BonoFill-II”) to help heal difficult fractures or bone gaps that aren’t healing on their own. It’s designed for people who have a serious bone injury in an arm or leg that needs stronger support to regenerate.

Afula
NCT06326827Not yet recruiting
Bone graft putty for arm or leg bone defects

This trial tests a bone graft putty called In'Oss to repair bone defects in the upper arm, forearm, thigh, or shin. It aims to see if it helps heal bone gaps during surgery.

NCT07062588Recruiting· Phase 2
AGA2115 for osteogenesis imperfecta in adults with COL1A1/COL1A2 variations

This trial tests a new drug called AGA2115 for people with osteogenesis imperfecta (also known as brittle bone disease) who have a confirmed genetic change in the COL1A1 or COL1A2 genes. The study aims to see if the drug can help strengthen bones and reduce fracture risk.

Phoenix, Arizona
NCT07557446Recruiting· Phase 2
Testing AGA2115 for Osteogenesis Imperfecta in Chinese Patients

This study tests a new medicine called AGA2115 in adults and teenagers with osteogenesis imperfecta (brittle bone disease). The trial aims to find the right dose and see if it can strengthen bones and reduce fracture risk.

Beijing, Beijing Municipality
NCT05732870Recruiting
Study looks for blood and gene signals that affect bone health

This study collects information and samples around the time of certain bone or joint surgeries (like joint replacement or fracture repair) to learn what factors help or harm bone healing. The results may help find better targets to improve long-term bone health and recovery.

London, Greater London

Hear when a new Patients With Fractures trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.